{"component": "definition", "props": {"groups": [{"snippet": "means a substance that, in relation to a controlled substance, has a substantially similar chemical structure.", "size": 10, "samples": [{"hash": "2sSsElqLkWC", "uri": "https://www.wvbop.com/www/download_resource.asp?id=426", "label": "www.wvbop.com", "score": 18.4524697142, "published": false}, {"hash": "h6BedyfMC6j", "uri": "https://www.wvlegislature.gov/Bill_Text_HTML/2023_SESSIONS/RS/bills/hb2019%20intr.docx", "label": "www.wvlegislature.gov", "score": 11.5106091718, "published": false}, {"hash": "4AzKDfqpHb8", "uri": "https://apps.sos.wv.gov/adlaw/csr/readfile.aspx?DocId=55916&Format=WORD&KeyWord=", "label": "apps.sos.wv.gov", "score": 10.0746064339, "published": false}], "snippet_links": [{"key": "in-relation-to", "type": "clause", "offset": [24, 38]}, {"key": "controlled-substance", "type": "definition", "offset": [41, 61]}, {"key": "substantially-similar", "type": "definition", "offset": [69, 90]}], "hash": "346d41a784e3ed180cad8965812fedef", "id": 1}, {"snippet": "means a BMS Compound that is structurally and functionally similar to a particular BMS Compound and is provided to Exelixis by BMS pursuant to Section 4.3 as a substitute for such BMS Compound.", "size": 5, "samples": [{"hash": "kRaZbPwYhOu", "uri": "/contracts/kRaZbPwYhOu#analogue", "label": "Research Collaboration and Technology Transfer Agreement (Exelixis Inc)", "score": 18.0, "published": true}, {"hash": "eATcaEe2gEZ", "uri": "/contracts/eATcaEe2gEZ#analogue", "label": "Research Collaboration and Technology Transfer Agreement (Exelixis Inc)", "score": 18.0, "published": true}, {"hash": "9cBr0xLNZ9V", "uri": "/contracts/9cBr0xLNZ9V#analogue", "label": "Research Collaboration and Technology Transfer Agreement (Exelixis Inc)", "score": 18.0, "published": true}], "snippet_links": [{"key": "bms-compound", "type": "definition", "offset": [8, 20]}, {"key": "similar-to", "type": "definition", "offset": [59, 69]}, {"key": "by-bms", "type": "clause", "offset": [124, 130]}, {"key": "section-43", "type": "clause", "offset": [143, 154]}], "hash": "b684f2a9e9a676b5cf1a25c352a68688", "id": 2}, {"snippet": "means any substance not listed in a Schedule to this Act whose chemical structure is substantially similar to any drug of abuse whose psychoactive effects it simulates;", "size": 5, "samples": [{"hash": "lYynalrGrzg", "uri": "https://lesotholii.org/akn/ls/act/2008/5/eng@2008-05-27/source.pdf", "label": "lesotholii.org", "score": 18.7264674415, "published": false}, {"hash": "cciCYUPc9xJ", "uri": "https://media.lesotholii.org/files/legislation/akn-ls-act-2008-5-eng-2008-05-27.pdf", "label": "media.lesotholii.org", "score": 11.4353182752, "published": false}, {"hash": "9TjpFXanc3t", "uri": "https://www.lesothotradeportal.org.ls/kcfinder/upload/files/DRUGS%20OF%20ABUSE%20ACT%202008.pdf", "label": "www.lesothotradeportal.org.ls", "score": 5.2080766598, "published": false}], "snippet_links": [{"key": "schedule-to", "type": "clause", "offset": [36, 47]}, {"key": "this-act", "type": "definition", "offset": [48, 56]}, {"key": "similar-to", "type": "definition", "offset": [99, 109]}, {"key": "drug-of-abuse", "type": "definition", "offset": [114, 127]}], "hash": "f5c66b665f9efb6b4a47ed4ac8e63973", "id": 3}, {"snippet": "means (i) a compound that [*] a compound [*] of [*] except for [*] or [*], or (ii) a compound that [*], by [*] of [*] a compound [*] of [*].", "size": 3, "samples": [{"hash": "lk2tiqwRtKF", "uri": "/contracts/lk2tiqwRtKF#analogue", "label": "License Agreement", "score": 30.8088535522, "published": true}, {"hash": "i2rtVIwYCTH", "uri": "/contracts/i2rtVIwYCTH#analogue", "label": "License Agreement (Portola Pharmaceuticals Inc)", "score": 23.970568104, "published": true}, {"hash": "cDeH7tM8nvT", "uri": "https://www.sec.gov/Archives/edgar/data/1269021/000119312513153305/d436765dex108.htm", "label": "License Agreement (Portola Pharmaceuticals Inc)", "score": 14.2772073922, "published": false}], "snippet_links": [], "hash": "39d64a6c03c37e68e99ef7815c31044f", "id": 4}, {"snippet": "means any chemical structure that is a structural homolog to, or derived from, the Compound and is covered by NOVO NORDISK Intellectual Property Rights.", "size": 2, "samples": [{"hash": "kag2gbxs1YT", "uri": "/contracts/kag2gbxs1YT#analogue", "label": "Exclusive License Agreement (Amicus Therapeutics Inc)", "score": 18.0, "published": true}, {"hash": "hzKeAHp4ybc", "uri": "/contracts/hzKeAHp4ybc#analogue", "label": "Exclusive License Agreement (Amicus Therapeutics Inc)", "score": 18.0, "published": true}], "snippet_links": [{"key": "covered-by", "type": "definition", "offset": [99, 109]}, {"key": "intellectual-property-rights", "type": "definition", "offset": [123, 151]}], "hash": "861de22cd04da53e96132ee4c75427a7", "id": 5}, {"snippet": "means each chemical compound within the literal scope of a Valid Patent Claim that covers at least one (1) Compound, which chemical compound is not the same as a Compound.", "size": 2, "samples": [{"hash": "iaNtvDIVjAt", "uri": "/contracts/iaNtvDIVjAt#analogue", "label": "Collaborative Discovery and Development Agreement (Evotec AG)", "score": 21.0, "published": true}, {"hash": "fTqSxkUFUvQ", "uri": "/contracts/fTqSxkUFUvQ#analogue", "label": "Collaborative Discovery and Development Agreement (Evotec AG)", "score": 21.0, "published": true}], "snippet_links": [{"key": "chemical-compound", "type": "definition", "offset": [11, 28]}, {"key": "scope-of", "type": "clause", "offset": [48, 56]}, {"key": "valid-patent-claim", "type": "definition", "offset": [59, 77]}], "hash": "d5e4cea2efb4c90a5b9a517412b9a0fc", "id": 6}, {"snippet": "means a structural analogue of Compound falling under the claims of any \u2587\u2587\u2587\u2587\u2587\u2587\u2587 Patent, which is developed and commercialized under this Agreement as a substitute for, and for the same indications as, 9 O-H risperidone palmitate (R 92670) or any salt or derivative thereof.", "size": 2, "samples": [{"hash": "4QTDfZJw4bn", "uri": "/contracts/4QTDfZJw4bn#analogue", "label": "License Agreement (Alkermes Plc.)", "score": 33.3141683778, "published": true}, {"hash": "79NsSbSg7L", "uri": "/contracts/79NsSbSg7L#analogue", "label": "License Agreement (Alkermes Plc.)", "score": 23.3894592745, "published": true}], "snippet_links": [{"key": "claims-of", "type": "clause", "offset": [58, 67]}, {"key": "this-agreement", "type": "clause", "offset": [132, 146]}], "hash": "8aec44027ef9a3c7341bcd09fe3ad59d", "id": 7}, {"snippet": "means any substance whose chemical structure is substantially similar to any dangerous drug whose psychoactive effects it simulates.", "size": 2, "samples": [{"hash": "dz55j3dWmG7", "uri": "http://www.ddb.gov.ph/images/Consolidated%20PROPOSAL%20br%203%20S.%202013%20new%20a.pdf", "label": "www.ddb.gov.ph", "score": 6.8850102669, "published": false}], "snippet_links": [{"key": "similar-to", "type": "definition", "offset": [62, 72]}, {"key": "dangerous-drug", "type": "definition", "offset": [77, 91]}], "hash": "47b0c56e4dfdf171db82e130edd57b35", "id": 8}, {"snippet": "means that the telecommunication channel is suitable for transfer of analogue signals within basic frequency band from 0Hz to 4kHz gross. Type of telecommunication technology used has no influence. It is however important that the telecommunication channel provides minimal delay. Considering that, most suitable technologies are copper or fiber optic cables, PLC links and radio links. Satellite or switched links are not suitable for such application.", "size": 1, "samples": [{"hash": "gJrfG0LmOwp", "uri": "http://www.veesta-world.com/pages/V-PLC9000%20-%20VP-9UPT%20Universal%20PLC%20General%20Description%20Manual%20V1-9-en.pdf", "label": "www.veesta-world.com", "score": 4.8904859685, "published": false}], "snippet_links": [{"key": "transfer-of", "type": "definition", "offset": [57, 68]}, {"key": "frequency-band", "type": "clause", "offset": [99, 113]}, {"key": "type-of", "type": "definition", "offset": [138, 145]}, {"key": "no-influence", "type": "clause", "offset": [184, 196]}, {"key": "considering-that", "type": "clause", "offset": [281, 297]}, {"key": "fiber-optic-cables", "type": "clause", "offset": [340, 358]}], "hash": "9e83cd1ace5e1a62da6116f4605a0659", "id": 9}, {"snippet": "means a substance not listed in the Schedules to this Act whose chemical structure is substantially similar to a drug of abuse that stimulates psychoactive effects;", "size": 1, "samples": [{"hash": "f138YcTeHMI", "uri": "https://uploads.mwp.mprod.getusinfo.com/uploads/sites/44/2022/05/narcotic_drugs.pdf", "label": "uploads.mwp.mprod.getusinfo.com", "score": 8.7002053388, "published": false}], "snippet_links": [{"key": "the-schedules", "type": "definition", "offset": [32, 45]}, {"key": "this-act", "type": "definition", "offset": [49, 57]}, {"key": "similar-to", "type": "definition", "offset": [100, 110]}, {"key": "drug-of-abuse", "type": "definition", "offset": [113, 126]}], "hash": "320ee896126288dfee8c53a80e8f02fe", "id": 10}], "next_curs": "ClUST2oVc35sYXdpbnNpZGVyY29udHJhY3RzcjELEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIRYW5hbG9ndWUjMDAwMDAwMGEMogECZW4YACAA", "definition": {"snippet": "means a substance that, in relation to a controlled substance, has a substantially similar chemical structure.", "size": 48, "title": "Analogue", "id": "analogue", "examples": ["<strong>Analogue</strong> and digital outputs of protected content are allowed if they meet the requirements in this section and if they are not forbidden elsewhere in this Agreement..", "<strong>Analogue</strong> and digital outputs of protected content are allowed if they meet the requirements in this section and if they are not forbidden elsewhere in this Agreement.", "If the Customer reports a fault in any PSTN / <strong>Analogue</strong> element of the Service, the default BT repair service levels applicable from time to time will apply (unless otherwise agreed in writing with the Supplier), details of which are set out on the Supplier\u2019s Website.", "For purposes of this Section 5.1.3, to \u201cencode, or direct to be encoded, using DOT\u201d means to direct or cause the setting of DOT so as to cause a Licensed Product to inhibit the output of both High Definition <strong>Analogue</strong> Output and Standard Definition <strong>Analogue</strong> Output, as well as to only allow output to protected Digital outputs which ensure that the content will not be further output on High Definition <strong>Analogue</strong> Output or Standard Definition <strong>Analogue</strong> Output, where permitted by local regulations.", "The Licensed Product may pass the audio portion of Controlled Content to mono, stereo and multichannel <strong>Analogue</strong> Audio Output.", "If Cephalon cannot provide sufficient Cephalon <strong>Analogue</strong> Compounds to Ambit as determined by the JRC, then Ambit may request to replace the applicable Ambit Target in the manner set forth in the last two sentences of Section 4.3.1. Ambit shall utilize such information and Cephalon <strong>Analogue</strong> Compounds solely for the purpose of performing more comprehensive analysis to define a subset of Cephalon Library Compounds and Cephalon <strong>Analogue</strong> Compounds that show the most promising activity against the Ambit Targets.", "Request for cancelling a campaign must be in writing (email) to Airmagine \u2022 Promotion- and <strong>Analogue</strong> Campaigns can be canceled without related fees up to 12 weeks prior to the first day of the original Schedule.", "Within [ * ] of receiving a particular <strong>Analogue</strong> from BMS, Exelixis shall evaluate the feasibility of identifying Target(s) for such <strong>Analogue</strong>.", "Support is provided by our Help Desk on 01977 660204 Monitoring Centre The Smart Hub can communicate with the monitoring centre using a number of different methods \u2022 IP protocols to suitably enabled monitoring centres delivered via the ethernet or 3G cellular connection \u2022 <strong>Analogue</strong> protocols using the cellular connection Monitoring centres need to be appropriately configured and you should speak to your supplier prior to using Smart Hub with your customers.", "<strong>Analogue</strong> Exchange Lines allow an End User to connect their equipment to make and receive calls over Public Electronic Communications Networks."], "related": [["isomer", "Isomer", "Isomer"], ["formulation", "Formulation", "Formulation"], ["biological", "Biological", "Biological"], ["receptor", "Receptor", "Receptor"], ["genocide", "genocide", "genocide"]], "related_snippets": [], "updated": "2025-07-06T21:58:36+00:00"}, "json": true, "cursor": ""}}